Cargando…

Genetic Analysis of CYP2C9 with Reference to Drug Response in Epilepsy Patients of Pakistan

Epilepsy is a major global issue. Epilepsy patients are treated with AED (antiepileptic drugs). Interindividual variability in drug response has been documented in several studies. The resistance to drug response may be attributed to genetic polymorphism. The current study was undertaken to investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maqbool, Hafsa, Saleem, Tayyaba, Sheikh, Nadeem, Ashfaq, Aqsa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817865/ https://www.ncbi.nlm.nih.gov/pubmed/35136381 http://dx.doi.org/10.1155/2022/1451007

Ejemplares similares

Genetic Analysis of Sodium Channel Genes in Pediatric Epilepsy Patients of Pakistan
por: Ashfaq, Aqsa, et al.
Publicado: (2022)

GABRG2 C588T Polymorphism Is Associated with Idiopathic Generalized Epilepsy but Not with Antiepileptic Drug Resistance in Pakistani Cohort
por: Saleem, Tayyaba, et al.
Publicado: (2022)

COVID-19 containment and its unrestrained impact on epilepsy management in resource-limited areas of Pakistan
por: Saleem, Tayyaba, et al.
Publicado: (2020)

Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy
por: El-Tallawy, Hamdy N, et al.
Publicado: (2021)

Variations in the frequencies of polymorphisms in the CYP2C9 gene in six major ethnicities of Pakistan
por: Ahmed, Sagheer, et al.
Publicado: (2020)

Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy
por: Lakhan, Ram, et al.
Publicado: (2011)

Mutational Analysis of Myoclonin1 Gene in Pakistani Juvenile Myoclonic Epilepsy Patients
por: Saleem, Tayyaba, et al.
Publicado: (2021)

Genetic variations in the drug metabolizing enzyme, CYP2E1, among various ethnic populations of Pakistan
por: Ahmed, Sagheer, et al.
Publicado: (2020)

CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment
por: Silvado, Carlos Eduardo, et al.
Publicado: (2018)

Pharmacogenetic evaluation of ABCB1, Cyp2C9, Cyp2C19 and methylene tetrahydrofolate reductase polymorphisms in teratogenicity of anti-epileptic drugs in women with epilepsy
por: Jose, Manna, et al.
Publicado: (2014)

Psychosocial Factors Affecting Drug Relapse among Youth in Punjab, Pakistan
por: Malik, Najma Iqbal, et al.
Publicado: (2023)

Association of CYP2C9 Genetic Variants with Vitiligo
por: Alzolibani, Abdullateef A., et al.
Publicado: (2014)

Combination Analysis in Genetic Polymorphisms of Drug-Metabolizing Enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese Population
por: Ota, Tomoko, et al.
Publicado: (2015)

Assembling a DNA barcode reference library for the spiders (Arachnida: Araneae) of Pakistan
por: Ashfaq, Muhammad, et al.
Publicado: (2019)

Barriers to gender equity for female healthcare academicians and researchers in Pakistan: Is it still an issue?
por: Malik, Madeeha, et al.
Publicado: (2023)

Impact of CYP2C9‐Interacting Drugs on Warfarin Pharmacogenomics
por: Agrawal, Saaket, et al.
Publicado: (2020)

Functional characterization of the defective CYP2C9 variant CYP2C9*18
por: Liu, Jian, et al.
Publicado: (2021)

Evaluation of Drug–Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P‐gp Substrates in Patients With an Advanced Solid Tumor
por: Xiao, Jim J., et al.
Publicado: (2018)

Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population
por: Zhao, Fang-Ling, et al.
Publicado: (2022)

Associations of CYP2C9 and CYP2C19 Pharmacogenetic Variation with Phenytoin‐Induced Cutaneous Adverse Drug Reactions
por: Fohner, Alison E., et al.
Publicado: (2020)

Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population
por: Kudzi, William, et al.
Publicado: (2009)

Eradication and Current Status of Poliomyelitis in Pakistan: Ground Realities
por: Ghafoor, Shazia, et al.
Publicado: (2016)

Global variation in CYP2C8–CYP2C9 functional haplotypes
por: Speed, William C, et al.
Publicado: (2009)

In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9
por: Nembri, Serena, et al.
Publicado: (2016)

Evaluation of drug interaction potential of zanubrutinib with cocktail probes representative of CYP3A4, CYP2C9, CYP2C19, P‐gp and BCRP
por: Ou, Ying C., et al.
Publicado: (2021)

CYP2C9 Variations and Their Pharmacogenetic Implications Among Diverse South Asian Populations
por: Nizamuddin, Sheikh, et al.
Publicado: (2021)

CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population
por: Arici, Merve, et al.
Publicado: (2017)

Genetic Polymorphisms and In Silico Mutagenesis Analyses of CYP2C9, CYP2D6, and CYPOR Genes in the Pakistani Population
por: Ahmed, Shabbir, et al.
Publicado: (2018)

Prosthetic valve thrombosis – association of genetic polymorphisms of VKORC1, CYP2C9 and CYP4F2 genes
por: SR, Kalpana, et al.
Publicado: (2019)

Determination of Pleiotropic Effect of Warfarin in VKORC1 and CYP2C9 Genotypes in Patients With Heart Valve Replacement
por: Shafique, Huma, et al.
Publicado: (2022)

Impact of genetic and non-genetic factors on hepatic CYP2C9 expression and activity in Hungarian subjects
por: Fekete, Ferenc, et al.
Publicado: (2021)

Prediction of the drug–drug interaction potential of the α1‐acid glycoprotein bound, CYP3A4/CYP2C9 metabolized oncology drug, erdafitinib
por: De Zwart, Loeckie, et al.
Publicado: (2021)

Differing Membrane Interactions of Two Highly Similar Drug-Metabolizing Cytochrome P450 Isoforms: CYP 2C9 and CYP 2C19
por: Mustafa, Ghulam, et al.
Publicado: (2019)

Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population
por: Sukprasong, Rattanaporn, et al.
Publicado: (2021)

CYP2C8 and CYP2C9 mRNA expression profile in the human fetus
por: Johansson, Maria, et al.
Publicado: (2014)

Insights into molecular mechanisms of drug metabolism dysfunction of human CYP2C9*30
por: Louet, Maxime, et al.
Publicado: (2018)

CYP2C9*3/*3 Gene Expression Affects the Total and Free Concentrations of Valproic Acid in Pediatric Patients with Epilepsy
por: Wu, Xikun, et al.
Publicado: (2021)

Morphometric parameters and food preference in relation to sex and reference hematological values for Upupa epops from Pakistan
por: Tahir, Rida, et al.
Publicado: (2022)

The Effects of H(2)S on the Activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in Vivo in Rat
por: Wang, Xianqin, et al.
Publicado: (2013)

CYP3A5∗3 and C3435T MDR1 Polymorphisms in Prognostication of Drug-Resistant Epilepsy in Children and Adolescents
por: Emich-Widera, Ewa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hg1cng0lkicheebrlda9a39v5j